These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 14535928)

  • 1. Studies on the safety and immunogenicity of the South African bluetongue virus serotype 2 monovalent vaccine: specific detection of the vaccine strain genome by RT-PCR.
    Hammoumi S; Breard E; Sailleau C; Russo P; Grillet C; Cetre-Sossah C; Albina E; Sanchis R; Pepin M; Guibert JM; Zientara S
    J Vet Med B Infect Dis Vet Public Health; 2003 Sep; 50(7):316-21. PubMed ID: 14535928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of the minimum protective dose for bluetongue virus serotype 2 and 8 vaccines in sheep.
    Modumo J; Venter EH
    J S Afr Vet Assoc; 2012 Aug; 83(1):17. PubMed ID: 23327131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular differentiation between NS1 gene of a field strain Bluetongue virus serotype 2 (BTV-2) and NS1 gene of an attenuated BTV-2 vaccine.
    Agüero M; Arias M; Romero LJ; Zamora MJ; Sánchez-Vizcaíno JM
    Vet Microbiol; 2002 May; 86(4):337-41. PubMed ID: 11955783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A monovalent attenuated serotype 2 bluetongue virus vaccine confers homologous protection in sheep.
    Hunter P; Modumo J
    Onderstepoort J Vet Res; 2001 Dec; 68(4):331-3. PubMed ID: 12026066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of an inactivated combined vaccine for protection of cattle against lumpy skin disease and bluetongue viruses.
    Es-Sadeqy Y; Bamouh Z; Ennahli A; Safini N; El Mejdoub S; Omari Tadlaoui K; Gavrilov B; El Harrak M
    Vet Microbiol; 2021 May; 256():109046. PubMed ID: 33780805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of genome segments 2, 7 and 10 of bluetongue viruses serotype 2 for differentiation between field isolates and the vaccine strain.
    Bréard E; Sailleau C; Coupier H; Mure-Ravaud K; Hammoumi S; Gicquel B; Hamblin C; Dubourget P; Zientara S
    Vet Res; 2003; 34(6):777-89. PubMed ID: 14746772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccines against bluetongue in Europe.
    Savini G; MacLachlan NJ; Sanchez-Vizcaino JM; Zientara S
    Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):101-20. PubMed ID: 17765305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of vaccination for bluetongue virus serotype 8 performed shortly before challenge and implications for animal trade.
    Spedicato M; Lorusso A; Salini R; Gennaro AD; Leone A; Teodori L; Casaccia C; Portanti O; Calistri P; Giovannini A; Savini G
    Prev Vet Med; 2017 Jan; 136():49-55. PubMed ID: 28010907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An inactivated vaccine for the control of bluetongue virus serotype 16 infection in sheep in Italy.
    Savini G; Ronchi GF; Leone A; Ciarelli A; Migliaccio P; Franchi P; Mercante MT; Pini A
    Vet Microbiol; 2007 Sep; 124(1-2):140-6. PubMed ID: 17499459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of a Bluetongue inactivated vaccine (serotypes 1 and 4) in sheep.
    Bamouh Z; Es-Sadeqy Y; Safini N; Douieb L; Omari Tadlaoui K; Martínez RV; García MA; Fassi-Fihri O; Elharrak M
    Vet Microbiol; 2021 Oct; 261():109212. PubMed ID: 34450450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective duration of immunity of an inactivated bluetongue (BTV) serotype 2 vaccine against a virulent BTV serotype 2 challenge in sheep.
    Hamers C; Rehbein S; Hudelet P; Blanchet M; Lapostolle B; Cariou C; Duboeuf M; Goutebroze S
    Vaccine; 2009 May; 27(21):2789-93. PubMed ID: 19366576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The epidemiology and diagnosis of bluetongue with particular reference to Corsica.
    Breard E; Hamblin C; Hammoumi S; Sailleau C; Dauphin G; Zientara S
    Res Vet Sci; 2004 Aug; 77(1):1-8. PubMed ID: 15120946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A one-year follow-up of antibody response in cattle and sheep after vaccination with serotype 8- and serotype 1-inactivated BT vaccines.
    Zanella G; Bréard E; Sailleau C; Zientara S; Viarouge C; Durand B
    Transbound Emerg Dis; 2014 Oct; 61(5):473-6. PubMed ID: 23331382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bluetongue virus in the French Island of Reunion.
    Bréard E; Sailleau C; Hamblin C; Zientara S
    Vet Microbiol; 2005 Apr; 106(3-4):157-65. PubMed ID: 15778021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation between field and vaccine strain of bluetongue virus serotype 16.
    Monaco F; Cammà C; Serini S; Savini G
    Vet Microbiol; 2006 Aug; 116(1-3):45-52. PubMed ID: 16713688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of three inactivated vaccines against bluetongue virus serotype 8 in sheep.
    Eschbaumer M; Hoffmann B; König P; Teifke JP; Gethmann JM; Conraths FJ; Probst C; Mettenleiter TC; Beer M
    Vaccine; 2009 Jun; 27(31):4169-75. PubMed ID: 19406189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Full-Genome Sequencing of Four Bluetongue Virus Serotype 11 Viruses.
    Vandenbussche F; Sailleau C; Rosseel T; Desprat A; Viarouge C; Richardson J; Eschbaumer M; Hoffmann B; De Clercq K; Bréard E; Zientara S
    Transbound Emerg Dis; 2015 Oct; 62(5):565-71. PubMed ID: 24750582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of inactivated bluetongue virus serotype 8 vaccine against virulent challenge in sheep and cattle.
    Hamers C; Galleau S; Chery R; Blanchet M; Besancon L; Cariou C; Werle-Lapostolle B; Hudelet P; Goutebroze S
    Vet Rec; 2009 Sep; 165(13):369-73. PubMed ID: 19783850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid generation of replication-deficient monovalent and multivalent vaccines for bluetongue virus: protection against virulent virus challenge in cattle and sheep.
    Celma CC; Boyce M; van Rijn PA; Eschbaumer M; Wernike K; Hoffmann B; Beer M; Haegeman A; De Clercq K; Roy P
    J Virol; 2013 Sep; 87(17):9856-64. PubMed ID: 23824810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of bluetongue Disabled Infectious Single Animal (DISA) vaccine for different serotypes by VP2 exchange or incorporation of chimeric VP2.
    Feenstra F; Pap JS; van Rijn PA
    Vaccine; 2015 Feb; 33(6):812-8. PubMed ID: 25510389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.